Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bellagio Medical is an Italian medical device company focused on developing innovative ophthalmic solutions, specifically in the field of interventional glaucoma. The company's flagship product is Titran, a novel titratable glaucoma drainage device designed to address the unpredictability of post-surgery aqueous outflow rates. Unlike traditional fixed-lumen devices, Titran features multiple filtration holes that can be sequentially opened post-implantation using a YAG or thermal laser at a standard slit lamp. This allows ophthalmologists to perform early and late titration of intraocular pressure tailored to each patient's healing process, significantly reducing the risks of hypotony, aqueous leaks, and choroidal detachment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bellagio.